Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

D Katinger; A Wagner; I Luque; S Crespillo; F Conejero-Lara; M Roger; C Martin; N Mouz; S Mourao; A Farsang; F Notka; K Malcolm; N Bosquet; R Le Grand; C Moog; A Cope; R Shattock; DJ Lewis; R El Habib

doi:10.1186/1742-4690-9-S2-P354

Back

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

Journal article

Peer reviewed

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

D Katinger, A Wagner, I Luque, S Crespillo, F Conejero-Lara, M Roger, C Martin, N Mouz, S Mourao, A Farsang, …

RETROVIROLOGY, Vol.9, ARTN P354

13/09/2012

DOI: https://doi.org/10.1186/1742-4690-9-S2-P354

Abstract

Science & Technology

Life Sciences & Biomedicine

Virology

VIROLOGY

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000309472100427&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

25 Record Views

1 Times Cited - Web of Science

Details

Title: Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans
Creators: D Katinger
A Wagner
I Luque
S Crespillo
F Conejero-Lara
M Roger
C Martin
N Mouz
S Mourao
A Farsang
F Notka
K Malcolm
N Bosquet
R Le Grand
C Moog
A Cope
R Shattock
DJ Lewis
R El Habib
Publication Details: RETROVIROLOGY, Vol.9, ARTN P354
Publisher: BIOMED CENTRAL LTD
Date published: 13/09/2012
Date submitted: 17/05/2017
Identifiers: 99514372002346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

Abstract

Files and links (1)

Metrics

Details

Usage Policy